Fig. 2.
Fig. 2. Urinary levels of Isoprostane-F2-III (upper panel) and Isoprostane-F2-VI (middle panel) and plasma prothrombin fragment F1+2 (lower panel) in patients positive for antiphospholipid antibodies (aPL+), in patients with systemic lupus erythematosus negative for the antiphospholipid antibodies (SLE aPL−), and in healthy subjects (HS). Statistical analysis was performed by Mann-Whitney-U test.

Urinary levels of Isoprostane-F2-III (upper panel) and Isoprostane-F2-VI (middle panel) and plasma prothrombin fragment F1+2 (lower panel) in patients positive for antiphospholipid antibodies (aPL+), in patients with systemic lupus erythematosus negative for the antiphospholipid antibodies (SLE aPL−), and in healthy subjects (HS). Statistical analysis was performed by Mann-Whitney-U test.

Close Modal

or Create an Account

Close Modal
Close Modal